Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Allotransplantation in HIV-Infected Patients with ESRD
NCT00009009Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jan 2001
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclosporine, mycophenolate mofetil and prednisone in end stage renal disease (ESRD), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jan 2001; status: completed.
02
Drugs
cyclosporinemycophenolate mofetilprednisone
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00009009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009009.